The National Guard Is Being Deployed in New Orleans for an Extended Period....
Supreme Court Hands Trump White House Brutal Defeat on National Guard Deployments
So, That's the Real Story Behind the Deported Chinese National That the NYT...
MS Now Host Wonders Why Trump Was So Against Releasing the Epstein Files....
The Most Anti-Trump Judge Just Ruled Against Trump Again
Recognizing Media Malfunctions With the Heckler Awards - Part 1: The Industry Technical...
This Heartwarming Story Out of North Carolina Will Put You in the Christmas...
Will a Judge Toss the Hannah Dugan Verdict? Her Defense Team Hopes So
The Left Always Eats Its Own
Sen. Kennedy Defends Trump on Venezuelan Oil Seizures: Sanctions Mean Nothing If You...
What Does it Mean to Be an American? Vivek Ramaswamy's AmericaFest Speech
Two Convicted in Plot to Kill Hundreds of Jews in ISIS-Inspired Terror Attack...
Islamic Terrorist Gets Life in Jail for '9/11 Style' Plot
HEARTBREAKING: Islamic Arsonists Destroy Christmas Display at Catholic Church in the West...
Koreans Dislike Successful American Tech Companies So Much, They’re Willing to Risk US-Kor...
Tipsheet

Meet the First Recipients of the Pfizer Vaccine

AP Photo/Richard Drewm Fuke

Margaret Keenan, a 90-year-old grandmother who turns 91 next week, became the first person to receive a dose of the Pfizer vaccine on Tuesday. She was given the shot at the UK's University Hospital Coventry at 6:31 a.m. She said she felt "so privileged to be the first person vaccinated against COVID-19."

Advertisement

"It's the best early birthday present I could wish for because it means I can finally look forward to spending time with my family and friends in the New Year after being on my own for most of the year," Keenan remarked.

Here in the U.S., the FDA is meeting on Thursday to discuss Pfizer's emergency authorization request. In clinical trials, the Pfizer vaccine candidate, which was developed in partnership with BioNTech, proved to be 95 percent effective and with "no serious safety concerns," a company statement read.

"The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform," the FDA's agenda for Thursday reads. "On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older."

A second candidate, developed by Moderna, was over 94 percent effective. They too have requested an emergency authorization and the FDA will be meeting about that vaccine on Dec. 17.

Advertisement

"I think there's every chance that we will look back on...(Tuesday) as marking a decisive turning point in the battle against coronavirus," Simon Stevens, the CEO of England's National Health Service, said after the first dose was administered.

By the way, the second person to get a dose of the Pfizer vaccine in the UK is an 81-year-old man named William Shakespeare. Seriously.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos